Sentinel lymph node biopsy in melanoma patients

Area of Science:

• Oncology
• Surgical Oncology
• Dermatology

Background:

• Accurate management of regional lymph nodes is crucial for cutaneous melanoma patients.
• Sentinel lymph node biopsy (SLNB) is increasingly utilized for staging melanoma.
• SLNB is a standard procedure for detecting occult nodal metastasis in intermediate-thickness melanomas.

Purpose of the Study:

• To evaluate the role of SLNB in melanoma staging and treatment.
• To assess the diagnostic accuracy of SLNB in identifying lymph node metastasis.
• To clarify the therapeutic implications of SLNB in melanoma management.

Main Methods:

• Intraoperative lymphatic mapping and sentinel lymph node biopsy (SLNB).
• SLNB as a minimally invasive staging procedure.
• Ongoing large-scale randomized trials comparing SLNB with complete lymphadenectomy versus observation.

Main Results:

• SLNB provides accurate staging for melanoma patients with no clinically detectable nodal disease.
• SLNB is the standard for detecting occult regional node metastasis in intermediate-thickness melanomas.
• The use of SLNB in thin melanomas is still under evaluation.

Conclusions:

• SLNB is an established staging procedure for melanoma.
• The therapeutic benefit of SLNB, particularly with complete lymphadenectomy, requires further investigation through ongoing trials.
• The optimal management strategy for melanoma patients with early lymph node metastases is yet to be definitively determined.